Reply to A.W. Chan et al.
作者信息
Gillespie Erin F, Vaynrub Max, Yang Jonathan T
机构信息
Erin F. Gillespie, MD, MPH, Department of Radiation Oncology, University of Washington, Seattle, WA, Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY; Max Vaynrub, MD, Department of Surgery, Orthopaedic Service, Memorial Sloan Kettering Cancer Center, New York, NY; and Jonathan T. Yang, MD, PhD, Department of Radiation Oncology, University of Washington, Seattle, WA, Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
出版信息
J Clin Oncol. 2024 Apr 10;42(11):1328-1329. doi: 10.1200/JCO.23.02566. Epub 2024 Feb 6.
Abstract
摘要
相似文献
1
Reply to A.W. Chan et al.
J Clin Oncol. 2024 Apr 10;42(11):1328-1329. doi: 10.1200/JCO.23.02566. Epub 2024 Feb 6.
2
Similarities and differences: Comment on Chan et al. (2021).
J Exp Psychol Anim Learn Cogn. 2021 Apr;47(2):216-217. doi: 10.1037/xan0000277.
3
Dr. Chan-Woo Jeong, et al.'s reply.
Cranio. 2019 Nov;37(6):408. doi: 10.1080/08869634.2019.1664546.
4
Chan et al. reply.
Phys Rev Lett. 1990 Feb 19;64(8):979. doi: 10.1103/PhysRevLett.64.979.
5
Reply to Chan-Tack et al.
J Infect Dis. 2013 Jan 1;207(1):198-9. doi: 10.1093/infdis/jis638. Epub 2012 Oct 22.
6
Reply to Chan et al.: Better delineating female and male sexual orientation.
Proc Natl Acad Sci U S A. 2021 Mar 23;118(12). doi: 10.1073/pnas.2100746118.
7
Reply to: Chan et al. "Temporal arteritis: neurological and ophthalmological involvement in the absence of documented systemic features".
Surv Ophthalmol. 2024 Jul-Aug;69(4):664. doi: 10.1016/j.survophthal.2024.02.002. Epub 2024 Feb 21.
8
Reply to Chan et al.
J Med Virol. 2023 Jan;95(1):e28283. doi: 10.1002/jmv.28283.
9
Diacylglycerol, phosphatidic acid, and their metabolic enzymes in synaptic vesicle recycling.
Adv Biol Regul. 2015 Jan;57:147-52. doi: 10.1016/j.jbior.2014.09.010. Epub 2014 Sep 28.
10
Comment on Chan W, Flowers AM, Meyer BI, et al. acute central retinal artery occlusion seen within 24 hours at a tertiary institution. J Stroke Cerebrovasc Dis 2021; 30:105988.
J Stroke Cerebrovasc Dis. 2022 May;31(5):106392. doi: 10.1016/j.jstrokecerebrovasdis.2022.106392. Epub 2022 Feb 24.
本文引用的文献
1
Prophylactic Radiation Therapy for High-Risk Asymptomatic Bone Metastases: A New Standard of Care or Need for More Data?
J Clin Oncol. 2024 Apr 10;42(11):1326-1327. doi: 10.1200/JCO.23.02391. Epub 2024 Feb 6.
2
Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study.
Lancet. 2024 Jan 13;403(10422):171-182. doi: 10.1016/S0140-6736(23)01857-3. Epub 2023 Dec 14.
3
Prophylactic Radiation Therapy Versus Standard of Care for Patients With High-Risk Asymptomatic Bone Metastases: A Multicenter, Randomized Phase II Clinical Trial.
J Clin Oncol. 2024 Jan 1;42(1):38-46. doi: 10.1200/JCO.23.00753. Epub 2023 Sep 25.
4
Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trial.
Lancet Oncol. 2022 Apr;23(4):501-513. doi: 10.1016/S1470-2045(22)00092-4. Epub 2022 Mar 10.
5
Early palliative radiation versus observation for high-risk asymptomatic or minimally symptomatic bone metastases: study protocol for a randomized controlled trial.
BMC Cancer. 2020 Nov 17;20(1):1115. doi: 10.1186/s12885-020-07591-w.
6
Spinal instability neoplastic score: an analysis of reliability and validity from the spine oncology study group.
J Clin Oncol. 2011 Aug 1;29(22):3072-7. doi: 10.1200/JCO.2010.34.3897. Epub 2011 Jun 27.
7
A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma.
J Natl Cancer Inst. 2002 Oct 2;94(19):1458-68. doi: 10.1093/jnci/94.19.1458.
8
Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures.
Clin Orthop Relat Res. 1989 Dec(249):256-64.
Zotero 插件